Science
Indica Labs Advance Immuno-oncology Capabilities with Innovative Qu...
Corrales, NM – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the release of a new module for multiplex chromogenic IHC analysis using HALO™. The Multiplex IHC...
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...
I love headlines such as these. First it was "Pigeons to Replace Pathologists in Diagnosing Benign from Malignant Tumors" now it is actual computer algorithms that get it right more times than and more so than ordinary surgical pathologists!...
When serum protein biomarker data were used independently, clinical sensitivity and specificity for detection of breast cancer were 74.7% and 77.0%, respectively. When tumor-associated autoantibody data were used independently,...
Webinar Date – Thursday, August 25th 2016, 4:00 – 5.00pm Join Eileen Regan, Key Account Manager as she presents and demonstrates how Xplore & TMA can facilitate collaborative research within your organization by enabling easy access,...